Boehringer wins PI against Dr. Reddy’s that blocks generic empagliflozin (Jardiance) sales in UK pending October 2026 trial: patent thickets work

To Read The Full Story

Continue reading your article with a Membership

Judge and counsel

8 New Square’s Michael Tappin KC made the decision in his capacity as Deputy Judge of the High Court.

Patentee Boehringer Ingelheim (defendant to the revocation claim, infringement counterclaimant) was represented by Thomas Mitcheson KC, Edward Cronan and Thomas Lunt, who were instructed by Kirkland & Ellis.

Dr. Reddy’s was represented by Mark Vanhegan KC and Christopher Hall (instructed by Penningtons Manches Cooper).

Andrew Lomas (instructed by the UK government’s Legal Department) appeared for the intervenor, the Secretary of State for Health and Social Care (SSHSC) of the UK.